Aspirin in the Secondary Prevention of Cardiovascular Disease

In 2007–2008, antiplatelet medications were prescribed at only 46.9% of visits for patients with ischemic vascular disease. The evidence of the benefit of aspirin with respect to cardiovascular outcomes underscores the substantial opportunity before clinicians and patients.